首页|Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia

Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
Aim:The aim of the current study was to evaluate the potential clinical impact of clonal evolution detected by fluorescence in situ hybridization (FISH) in untreated chronic lymphocytic leukaemia (CLL) patients managed with a watch-and-wait strategy.Methods: We performed both overall survival (OS) and time to first treatment (TTFT) analysis. For the first one, we exploited a real-life cohort of 123 consecutive CLL patients followed at our institution, for which at least a second FISH evaluation during watch and wait was available. For TTFT analysis, we considered only patients treated after the second FISH sample (n = 69).Results: Considering the original cohort, patients who acquired a FISH abnormality displayed a worse outcome with a median OS of 91.9 months compared to 147.3 months for patients who did not acquire any FISH abnormalities (P = 0.007). Unmutated immunoglobulin heavy chain gene (IGHV) genes were associated with a higher probability of acquiring a FISH abnormality (P = 0.04). Turning to TTFT analysis, patients who gained at least one FISH abnormality (n = 7, 10％) were characterised by an earlier treatment requirement with a median TTFT of 1.1 months, compared to 2.7 months in patients who did not acquire any FISH abnormalities (n=62,90％) (P=0.025).Conclusions: The dynamic acquisition of karyotypic abnormalities by FISH predicts poor outcomes and early treatment requirement in CLL patients. Our results suggest that FISH analysis could be integrated with other clinical and biological features to obtain dynamic scores that are able to predict outcomes at different phases of disease history.

Chronic lymphocytic leukaemiaFISH analysisclonal evolution

Riccardo Dondolin、Matteo Bellia、Silvia Rasi、Clara Deambrogi、Donatella Talotta、Samir Mouhssine、Wael Al Essa、Abdurraouf Mokhtar Mahmoud、Danilo Faraci、Gianluca Gaidano、Riccardo Moia

展开 >

Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore Della Carità, Novara 28100, Italy

Molecular bases of disease dissemination in lymphoid malignancies to optimize curative therapeutic strategiesAssociazione Italiana per la Ricerca sul Cancro Foundation Milan,ItalyPNRR-MAD-12375673,Italian MoH,Rome,Italy(2022)PNRR-MAD-12375673,Italian MoH,Rome,Italy(2022)AGING Project(Department of Excellence),DIMET,Università del Piemonte Orientale,Novara,Italy

51000 21198Next Generation EUM6/C2_CALL 2022

2024

10.20517/2394-4722.2023.131

癌症转移与治疗(英文版)

癌症转移与治疗(英文版)

ISSN：
年,卷(期)：2024.10(1)
  • 15